Skip to main content
CDC Website

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Isoniazid y Rifapentine

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.
Author:
Oregon Health Authority, Public Health Division
Format:
Information Sheet
Publication Date:
2013
  • Adolescents/Youth/Teens
  • Adults
  • Black or African American persons
  • At Risk Persons
  • Parents/Families
  • Non-U.S.-born persons
  • General Public
  • Hispanic or Latino persons
  • People experiencing homelessness
  • American Indian or Alaska Native persons
  • Older Adults
  • Persons with TB
  • TB
  • Counseling
  • TB
Was this page helpful? Give Feedback